Home/Myriel/Karen Hsiao Ashe, MD, PhD

KH

Karen Hsiao Ashe, MD, PhD

CEO, Co-Founder, Professor

Therapeutic Areas

Neurology Neurodegenerative Diseases

Myriel Pipeline

Drug	Indication	Phase
MUR-2425	Memory loss in mild to moderate dementia (Alzheimer's, Parkinson's, Lewy body, Huntington's, etc.)	Pre-clinical

Leadership Team at Myriel

Steffen Pockes, PhD

Co-Founder, Professor (Medicinal Chemistry)

Michael A. Walters, PhD

Co-Founder, Research Associate Professor (Medicinal Chemistry)

View full Myriel profile